Vivani Medical, Inc.
General ticker "VANI" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $72.5M (TTM average)
Vivani Medical, Inc. follows the US Stock Market performance with the rate: 36.1%.
Estimated limits based on current volatility of 5.6%: low 1.17$, high 1.32$
Factors to consider:
- Total employees count: 44 (+214.3%) as of 2023
- Top business risk factors: Early stage and no commercial products, Manufacturing disruptions, Operational and conduct risks, Regulatory and compliance, Cybersecurity threats
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.92$, 2.23$]
- 2026-12-31 to 2027-12-31 estimated range: [0.88$, 2.14$]
Financial Metrics affecting the VANI estimates:
- Positive: with PPE of -3.1 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -29.44 <= 0.07
- Positive: 19.49 < Shareholder equity ratio, % of 39.93 <= 42.60
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -4.45 < Investing cash flow per share per price, % of -1.42
Short-term VANI quotes
Long-term VANI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $26.96MM | $24.68MM | $27.56MM |
| Operating Income | $-26.96MM | $-24.68MM | $-27.56MM |
| Non-Operating Income | $1.31MM | $1.19MM | $0.95MM |
| R&D Expense | $16.97MM | $15.74MM | $18.13MM |
| Income(Loss) | $-25.65MM | $-23.49MM | $-26.61MM |
| Profit(Loss)* | $-25.65MM | $-23.49MM | $-26.61MM |
| Stockholders Equity | $20.76MM | $17.61MM | $15.73MM |
| Assets | $45.80MM | $41.56MM | $39.39MM |
| Operating Cash Flow | $-23.70MM | $-20.79MM | $-24.32MM |
| Capital expenditure | $0.89MM | $0.56MM | $1.17MM |
| Investing Cash Flow | $-0.89MM | $-0.56MM | $-1.17MM |
| Financing Cash Flow | $0.13MM | $19.05MM | $23.27MM |
| Earnings Per Share** | $-0.50 | $-0.43 | $-0.43 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.